Figure 1.
(A) Chemical structures of the investigational anticoronaviral agent S-217622 (along with its expected comprehensive extended and broad-spectrum anticoronaviral activities against the diverse nonspecific proteins of coronaviruses) and the reference anti-SARS-CoV-2 drug molnupiravir, respectively. (B) Comparative physicochemical radar (preliminary in silico pharmacokinetics/druglikeness assessment; LIPO: Lipophilicity, INSOLU: Insolubility, INSATU: Insaturation, and FLEX: Flexibility) of S-217622 versus molnupiravir, generated using the SwissADME webserver.